Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design and Development of IKZF2 and CK1α Dual Degraders. | J Med Chem | 2023 | 38085607 | PubTator, text mining | PubMed |
| Harnessing PROTAC technology to combat stress hormone receptor activation. | Nat Commun | 2023 | 38071198 | PubTator, text mining | PubMed |
| 5-Aza-2'-Deoxycytidine Alters the Methylation Profile of Bortezomib-Resistant U266 Multiple Myeloma Cells and Affects Their Proliferative Potential. | Int J Mol Sci | 2023 | 38069103 | PubTator, text mining | PubMed |
| Developing New Strategies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma. | J Clin Med | 2023 | 38068428 | PubTator, text mining | PubMed |
| In vitro substrate reduction, chaperone and immunomodulation treatments reduce heparan sulfate in mucolipidosis III human fibroblasts. | Genet Mol Biol | 2023 | 38047750 | PubTator, text mining | PubMed |
| Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas. | Haematologica | 2023 | 38037799 | PubTator, text mining | PubMed |
| Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization. | Haematologica | 2023 | 38037798 | PubTator, text mining | PubMed |
| Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype. | Nat Commun | 2023 | 38036533 | PubTator, text mining | PubMed |
| Identification of non-conventional small molecule degraders and stabilizers of squalene synthase. | Chem Sci | 2023 | 38023519 | PubTator, text mining | PubMed |
| The Relationship Between the Expression of CRBN in Peripheral Blood and the Severity and Prognosis of Adult Sepsis. | Int J Gen Med | 2023 | 38021046 | PubTator, text mining | PubMed |
| Discovery of a selective TC-PTP degrader for cancer immunotherapy. | Chem Sci | 2023 | 38020389 | PubTator, text mining | PubMed |
| Pervasive aggregation and depletion of host and viral proteins in response to cysteine-reactive electrophilic compounds. | bioRxiv | 2023 | 38014036 | PubTator, text mining | PubMed |
| IMiD-Free Interval and IMiDs Sequence: Which Strategy Is Better Suited for Lenalidomide-Refractory Myeloma? | Life (Basel) | 2023 | 38004369 | PubTator, text mining | PubMed |
| PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas. | Int J Mol Sci | 2023 | 38003535 | PubTator, text mining | PubMed |
| Multiple Myeloma in 2023 Ways: From Trials to Real Life. | Curr Oncol | 2023 | 37999125 | PubTator, text mining | PubMed |
| DegronMD: Leveraging Evolutionary and Structural Features for Deciphering Protein-Targeted Degradation, Mutations, and Drug Response to Degrons. | Mol Biol Evol | 2023 | 37992195 | PubTator, text mining | PubMed |
| Covalent Stapling of the Cereblon Sensor Loop Histidine Using Sulfur-Heterocycle Exchange. | ACS Med Chem Lett | 2023 | 37974938 | PubTator, text mining | PubMed |
| Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy. | Acta Pharm Sin B | 2023 | 37969742 | PubTator, text mining | PubMed |
| Glucokinase Variant Proteins Are Resistant to Fasting-Induced Uridine Diphosphate Glucose-Dependent Degradation in Maturity-Onset Diabetes of the Young Type 2 Patients. | Int J Mol Sci | 2023 | 37958824 | PubTator, text mining | PubMed |
| IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial. | Nat Med | 2023 | 37957373 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=27